Puts Purchased on Jazz Pharmaceuticals (JAZZ)

Shares of Jazz Pharmaceuticals JAZZ are lower on the session by 1.37%, currently trading at $18.69. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today. A short while ago the December $20.00 put was purchased 1,200 times, on the offer, for $1.39 on open interest of only 20 contracts. This signals new positioning on the name. Overall put volume is now running at 10.55x the daily average with 98% of all puts traded being purchases on the offer. Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on the development and commercialization of pharmaceutical products to meet unmet medical needs in neurology and psychiatry.